查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1442495

α 淀粉酶的全球市场 - 全球产业分析、规模、占有率、成长、趋势、预测 (2031) - 按形式、按应用、按原料、按地区

Alpha Amylase Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 300 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球 α 淀粉酶市场规模预计将从 2023 年的 18 亿美元快速成长到 2031 年底的 25 亿美元。

消费者健康意识的提高正在导致食品消费模式发生重大变化。 随着消费者的健康意识越来越强，他们越来越喜欢有益于健康和营养的产品。 α淀粉酶以其消化健康益处和免疫系统支持而闻名，并且需求随着这一趋势而不断增加。 消费者对健康食品选择的认识不断增强，市场可望受益。

在製药业，对 α 淀粉酶的需求不断增长，因为它具有多种健康益处，包括免疫系统支持、发炎管理和血糖水平正常化。 科学证明，α 淀粉酶可帮助消化并提供能量，在医学上具有广泛的应用，可对抗消化系统疾病并支持整体健康。 由于久坐的生活方式和不健康的饮食导致胃肠道疾病的增加，製药业为 α 淀粉酶市场的扩张提供了一个充满希望的途径。

欧洲在全球 α 淀粉酶市场展现压倒性的实力，2023 年销售占有率最高，达 28.0%。 该地区先进的生物技术产业和广泛的最终用户群有助于其市场领先地位，并为持续成长和创新奠定了基础。

在南亚，α 淀粉酶市场预计到 2031 年底将显着成长。 该地区的复合年增长率预计为 9.4%，消费者偏好的变化以及食品和製药行业的扩张将推动该地区的发展，为市场参与者提供利润丰厚的机会。

本报告调查了全球 α 淀粉酶市场，并提供了市场概况、按形式、应用、原材料、地区划分的趋势以及进入市场的公司的竞争趋势。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第三章2018-2023年生产与贸易统计

第 4 章价格分析，2018-2023

第 5 章 2018-2031 年全球 α 淀粉酶市场前景

  • 2018-2031 年全球 α 淀粉酶市场前景，以形式、价值（十亿美元）、数量（单位）划分
  • 2018-2031 年全球 α 淀粉酶市场前景（按应用划分）、价值（十亿美元）、数量（单位）
  • 2018-2031 年全球 α 淀粉酶市场前景（按原料、价值（十亿美元）、数量（单位））
  • 2018-2031 年全球 α 淀粉酶市场前景（按地区、价值（十亿美元）、数量（单位））

第 6 章北美 α 淀粉酶市场展望，2018-2031

第 7 章欧洲 α-淀粉酶市场展望，2018-2031

第 8 章亚太地区 α 淀粉酶市场展望，2018-2031

第 9 章拉丁美洲 α 淀粉酶市场前景，2018-2031

第 10 章中东与非洲 α 淀粉酶市场前景，2018-2031 年

第十一章竞争态势

  • 以最终使用者和使用情况划分的热图
  • 2022 年公司市占率分析
  • 竞争对手仪表板
  • 公司简介
    • Novozymes
    • Aumgene Biosciences
    • Lee BioSolutions
    • AB Enzymes
    • Infinita Biotech Private Limited
    • Jiangsu Boli Bioproducts Co., Ltd.
    • Actiza Pharmaceutical Private Limited
    • Brisk Bioscience.
    • Sisco Research Laboratories Pvt Ltd
    • Karyotica Biologicals
    • Biolaxi Corporation
    • Creative Enzymes
    • Rejoice Life Ingredients
    • Enzyme Bioscience Pvt. Ltd.
    • Sunson Industry Group Co., Ltd.

第12章附录

简介目录

The global alpha amylase market is set to witness robust growth in the coming years, according to a comprehensive market analysis covering the period from 2024 to 2031. The market is anticipated to surge from US$ 1.8 billion in 2023 to a staggering US$ 2.5 billion by the end of 2031. The analysis, which delves into various aspects of the market landscape, sheds light on key trends, regional insights, category-wise outlook, and competitive dynamics shaping the alpha amylase industry.

Rising Consumer Awareness Regarding Health Beneficial Products

Increasing consumer awareness regarding health and wellness is driving significant shifts in food consumption patterns. As consumers become more health-conscious, there is a growing preference for products offering enhanced health and nutrition benefits. Alpha amylase, known for its digestive health benefits and immune system support, is witnessing increased demand in line with this trend. The market is poised to benefit from this heightened consumer consciousness towards healthier food choices.

Bio-preservation Trend Fuelling Alpha Amylase Demand in Food Industry

Bio-preservation, aimed at extending the shelf life of food products through natural means, is gaining traction among consumers seeking safer and fresher food options. With artificial preservatives falling out of favor, alpha amylase emerges as a crucial component in the bio-preservation process. Its ability to maintain food freshness while meeting safety standards aligns with consumer preferences for clean label, natural products, thus driving its demand across various food sectors including dairy, beverages, and bakery.

Increasing Demand of Alpha Amylase in Pharmaceutical Industry to Bolster Sales

The pharmaceutical industry is witnessing a growing demand for alpha amylase, attributed to its various health benefits including immune system support, inflammation management, and blood sugar normalization. Scientifically proven to aid digestion and provide energy, alpha amylase is finding extensive applications in medicines aimed at addressing digestive disorders and supporting overall health. With sedentary lifestyles and unhealthy dietary habits contributing to the rise in digestive issues, the pharmaceutical sector presents a promising avenue for alpha amylase market expansion.

High Cost of Alpha Amylase to Hamper Sales

Despite its promising prospects, the high cost associated with alpha amylase remains a significant challenge for market growth. The intricate production process and sensitivity to environmental factors contribute to its expensive nature, deterring potential customers. While advancements in production methods have opened new possibilities, the premium pricing of alpha amylase continues to pose hurdles in widespread adoption.

Country-wise Insights

Europe Dominates Global Alpha Amylase Market

Europe emerges as the dominant force in the global alpha amylase market, boasting the highest volume share of 28.0% in 2023. The region's advanced biotechnology industry and extensive end-user base contribute to its market leadership, setting the stage for continued growth and innovation.

South Asia Presents Promising Growth Opportunities

In South Asia, the alpha amylase market is forecasted to exhibit substantial growth by the end of 2031. With a projected CAGR of 9.4%, the region presents lucrative opportunities for market players, fueled by evolving consumer preferences and expanding food and pharmaceutical sectors.

Category-wise Insights

Bakery Segment to Witness Steady Growth

Within the food and beverage industry, the bakery segment stands out with a projected CAGR of 8.3%. Alpha amylase's ability to enhance shelf life and improve baking volume positions it as a valuable ingredient in bakery products, driving market growth. Additionally, the demand for alpha amylase in confectionary and bio-preservation applications is on the rise, further bolstering market prospects.

Powder Form Dominates Market Share

Among different forms of alpha amylase, powder holds the largest market share, accounting for 79.3% of the global market. Its easy availability and versatility make it a preferred choice for various applications, although liquid alpha amylase is also witnessing increasing demand owing to its diverse application possibilities.

Competitive Analysis

Leading players in the global alpha amylase market, including Novozymes, Lee BioSolution, and AB Enzymes, are focusing on product diversification and research and development initiatives to maintain their competitive edge. Strategic partnerships, acquisitions, and custom manufacturing services are key strategies employed by these players to expand their market presence and cater to evolving customer needs.

The market also sees active participation from companies such as Aumgene Biosciences, Jiangsu Boli Bioproducts Co., Ltd., Ottokemi, Lee Biosolutions, Inc., and Karyotica Biologicals Pvt. Ltd., each leveraging unique capabilities and strategies to capitalize on emerging opportunities and drive innovation within the industry.

Alpha Amylase Industry Research by Category

By Form:

  • Powder & Granules
  • Liquid

By Application:

  • Food & Beverage Industry
    • Confectionery
    • Bakery
    • Brewing
    • Other Processed Food
  • Pharmaceuticals
  • Animal Feed
  • Research
  • Detergent
  • Others

By Source:

  • Bacteria
  • Fungi
  • Plants & Animals

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Alpha Amylase Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Ankle Syndesmosis Treatment Devices Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Form, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Ankle Syndesmosis Treatment Devices Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Alpha Amylase Market Outlook, 2018 - 2031

  • 5.1. Global Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Powder & Granules
      • 5.1.1.2. Liquid
  • 5.2. Global Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Food & Beverage Industry
        • 5.2.1.1.1. Confectionery
        • 5.2.1.1.2. Bakery
        • 5.2.1.1.3. Brewing
        • 5.2.1.1.4. Other Processed Food
      • 5.2.1.2. Pharmaceuticals
      • 5.2.1.3. Animal Feed
      • 5.2.1.4. Research
      • 5.2.1.5. Detergent
      • 5.2.1.6. Others
  • 5.3. Global Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Bacteria
      • 5.3.1.2. Fungi
      • 5.3.1.3. Plants & Animals
  • 5.4. Global Alpha Amylase Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Alpha Amylase Market Outlook, 2018 - 2031

  • 6.1. North America Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Powder & Granules
      • 6.1.1.2. Liquid
  • 6.2. North America Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Food & Beverage Industry
        • 6.2.1.1.1. Confectionery
        • 6.2.1.1.2. Bakery
        • 6.2.1.1.3. Brewing
        • 6.2.1.1.4. Other Processed Food
      • 6.2.1.2. Pharmaceuticals
      • 6.2.1.3. Animal Feed
      • 6.2.1.4. Research
      • 6.2.1.5. Detergent
      • 6.2.1.6. Others
  • 6.3. North America Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Bacteria
      • 6.3.1.2. Fungi
      • 6.3.1.3. Plants & Animals
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.2. U.S. Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.3. U.S. Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.4. Canada Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.5. Canada Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.6. Canada Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Alpha Amylase Market Outlook, 2018 - 2031

  • 7.1. Europe Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Powder & Granules
      • 7.1.1.2. Liquid
  • 7.2. Europe Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Food & Beverage Industry
        • 7.2.1.1.1. Confectionery
        • 7.2.1.1.2. Bakery
        • 7.2.1.1.3. Brewing
        • 7.2.1.1.4. Other Processed Food
      • 7.2.1.2. Pharmaceuticals
      • 7.2.1.3. Animal Feed
      • 7.2.1.4. Research
      • 7.2.1.5. Detergent
      • 7.2.1.6. Others
  • 7.3. Europe Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Bacteria
      • 7.3.1.2. Fungi
      • 7.3.1.3. Plants & Animals
    • 7.3.2. Attractiveness Analysis
  • 7.4. Europe Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.2. Germany Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.3. Germany Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.4. U.K. Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.5. U.K. Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.6. U.K. Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.7. France Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.8. France Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.9. France Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.10. Italy Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.11. Italy Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.12. Italy Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.13. Turkey Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.14. Turkey Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.15. Turkey Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.16. Russia Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.17. Russia Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.18. Russia Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.19. Rest of Europe Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.20. Rest of Europe Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.21. Rest of Europe Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Alpha Amylase Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Powder & Granules
      • 8.1.1.2. Liquid
  • 8.2. Asia Pacific Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Food & Beverage Industry
        • 8.2.1.1.1. Confectionery
        • 8.2.1.1.2. Bakery
        • 8.2.1.1.3. Brewing
        • 8.2.1.1.4. Other Processed Food
      • 8.2.1.2. Pharmaceuticals
      • 8.2.1.3. Animal Feed
      • 8.2.1.4. Research
      • 8.2.1.5. Detergent
      • 8.2.1.6. Others
  • 8.3. Asia Pacific Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Bacteria
      • 8.3.1.2. Fungi
      • 8.3.1.3. Plants & Animals
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.2. China Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.3. China Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.4. Japan Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.5. Japan Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.6. Japan Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.7. South Korea Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.8. South Korea Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.9. South Korea Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.10. India Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.11. India Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.12. India Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.13. Southeast Asia Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.14. Southeast Asia Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.15. Southeast Asia Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Alpha Amylase Market Outlook, 2018 - 2031

  • 9.1. Latin America Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Powder & Granules
      • 9.1.1.2. Liquid
  • 9.2. Latin America Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.2.1.1. Food & Beverage Industry
        • 9.2.1.1.1. Confectionery
        • 9.2.1.1.2. Bakery
        • 9.2.1.1.3. Brewing
        • 9.2.1.1.4. Other Processed Food
      • 9.2.1.2. Pharmaceuticals
      • 9.2.1.3. Animal Feed
      • 9.2.1.4. Research
      • 9.2.1.5. Detergent
      • 9.2.1.6. Others
  • 9.3. Latin America Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Bacteria
      • 9.3.1.2. Fungi
      • 9.3.1.3. Plants & Animals
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.2. Brazil Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.3. Brazil Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.4. Mexico Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.5. Mexico Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.6. Mexico Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.7. Argentina Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.8. Argentina Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.9. Argentina Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Alpha Amylase Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Alpha Amylase Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. Powder & Granules
      • 10.1.1.2. Liquid
  • 10.2. Middle East & Africa Alpha Amylase Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Food & Beverage Industry
        • 10.2.1.1.1. Confectionery
        • 10.2.1.1.2. Bakery
        • 10.2.1.1.3. Brewing
        • 10.2.1.1.4. Other Processed Food
      • 10.2.1.2. Pharmaceuticals
      • 10.2.1.3. Animal Feed
      • 10.2.1.4. Research
      • 10.2.1.5. Detergent
      • 10.2.1.6. Others
  • 10.3. Middle East & Africa Alpha Amylase Market Outlook, by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Bacteria
      • 10.3.1.2. Fungi
      • 10.3.1.3. Plants & Animals
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Alpha Amylase Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.2. GCC Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.3. GCC Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.4. South Africa Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.5. South Africa Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.6. South Africa Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.7. Egypt Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.8. Egypt Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.9. Egypt Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.10. Nigeria Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.11. Nigeria Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.12. Nigeria Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Alpha Amylase Market by Form, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Alpha Amylase Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Alpha Amylase Market by Source, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By End User vs by Application Heatmap
  • 11.2. Company Market Share Analysis, 2022
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Novozymes
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Product Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. Aumgene Biosciences
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Product Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. Lee BioSolutions
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Product Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. AB Enzymes
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Product Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Infinita Biotech Private Limited
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Product Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Jiangsu Boli Bioproducts Co., Ltd.
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Product Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. Actiza Pharmaceutical Private Limited
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Product Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. Brisk Bioscience.
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Product Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Sisco Research Laboratories Pvt Ltd
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Product Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development
    • 11.4.10. Karyotica Biologicals
      • 11.4.10.1. Company Overview
      • 11.4.10.2. Product Portfolio
      • 11.4.10.3. Financial Overview
      • 11.4.10.4. Business Strategies and Development
    • 11.4.11. Biolaxi Corporation
      • 11.4.11.1. Company Overview
      • 11.4.11.2. Product Portfolio
      • 11.4.11.3. Financial Overview
      • 11.4.11.4. Business Strategies and Development
    • 11.4.12. Creative Enzymes
      • 11.4.12.1. Company Overview
      • 11.4.12.2. Product Portfolio
      • 11.4.12.3. Financial Overview
      • 11.4.12.4. Business Strategies and Development
    • 11.4.13. Rejoice Life Ingredients
      • 11.4.13.1. Company Overview
      • 11.4.13.2. Product Portfolio
      • 11.4.13.3. Financial Overview
      • 11.4.13.4. Business Strategies and Development
    • 11.4.14. Enzyme Bioscience Pvt. Ltd.
      • 11.4.14.1. Company Overview
      • 11.4.14.2. Product Portfolio
      • 11.4.14.3. Financial Overview
      • 11.4.14.4. Business Strategies and Development
    • 11.4.15. Sunson Industry Group Co., Ltd.
      • 11.4.15.1. Company Overview
      • 11.4.15.2. Product Portfolio
      • 11.4.15.3. Financial Overview
      • 11.4.15.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations